Kiran Mazumdar-Shaw is nothing if not innovative.
Starting with a postgraduate degree in brewing from an Australian university, she built the largest biopharmaceutical company in India.
And, along the way, she dispensed with antagonistic unionists by automating her production line; developed and patented a solid substrate bioreactor that facilitated the cultivation and extraction of microorganisms used in the production of industrial enzymes; skirted around international patents with a revolutionary method for manufacturing human insulin in yeast; created new therapies for both psoriasis and cancer of the head and neck; and established a micro-insurance program that has the potential to provide quality health care and medicines to millions of Indian villagers for an annual fee of just $3 per head.
"The difference lies in our DNA"
It is certainly not a misfortune. English is a global lingua Franca n countries r envious of India becos we have b… https://t.co/vdxLGZrCo7— Kiran Mazumdar Shaw (@kiranshaw) June 24, 2017
Meet Bugworks, India biotech working on innovative AMR products - BioPharma Asia Convention News https://t.co/SeX7YiDk6P— Kiran Mazumdar Shaw (@kiranshaw) June 24, 2017